Pulmonx (LUNG) Other Non-Current Assets (2019 - 2025)
Pulmonx's (LUNG) quarterly Other Non-Current Assets came in at $1.4 million in Q4 2025, up 25.18% year-over-year from $1.1 million in Q4 2024, and down 6.26% quarter-over-quarter from $1.5 million in Q3 2025.
Powered by 
Analysis
Pulmonx (LUNG) Other Non-Current Assets (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Other Non-Current Assets for 7 consecutive years, with $1.4 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Other Non-Current Assets rose 25.18% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 25.18% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 25.18% from the prior year.
- Other Non-Current Assets was $1.4 million for Q4 2025 at Pulmonx, down from $1.5 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $1.5 million in Q3 2025 and troughed at $231000.0 in Q1 2021.
- A 5-year average of $475600.0 and a median of $257000.0 in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets sank 44.85% in 2024 and surged 487.98% in 2025, its largest moves.
- Over 5 years, Other Non-Current Assets stood at $731000.0 in 2021, then declined by 27.63% to $529000.0 in 2022, then gained by 11.72% to $591000.0 in 2023, then jumped by 92.22% to $1.1 million in 2024, then climbed by 25.18% to $1.4 million in 2025.
- The last three Other Non-Current Assets figures came in at $1.4 million (Q4 2025), $1.5 million (Q3 2025), and $259000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Pulmonx | 75.94 Mn | 6.19 Mn | - | 1.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.42 Mn |
| Sep 30, 2025 | 1.52 Mn |
| Jun 30, 2025 | 259,000.00 |
| Mar 31, 2025 | 257,000.00 |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 258,000.00 |
| Jun 30, 2024 | 257,000.00 |
| Mar 31, 2024 | 236,000.00 |
| Dec 31, 2023 | 591,000.00 |
| Sep 30, 2023 | 236,000.00 |
| Jun 30, 2023 | 466,000.00 |
| Mar 31, 2023 | 231,000.00 |
| Dec 31, 2022 | 529,000.00 |
| Sep 30, 2022 | 231,000.00 |
| Jun 30, 2022 | 231,000.00 |
| Mar 31, 2022 | 231,000.00 |
| Dec 31, 2021 | 731,000.00 |
| Sep 30, 2021 | 231,000.00 |
| Jun 30, 2021 | 231,000.00 |
| Mar 31, 2021 | 231,000.00 |